Cannabis Use in Cancer Patients Six Years Post-Legalization in Canada

IF 1.3 Q3 RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING
Meagan Carty , Andie Saade , Kye Rajaraman , Neyousha Shahisavandi , Murali Rajaraman
{"title":"Cannabis Use in Cancer Patients Six Years Post-Legalization in Canada","authors":"Meagan Carty ,&nbsp;Andie Saade ,&nbsp;Kye Rajaraman ,&nbsp;Neyousha Shahisavandi ,&nbsp;Murali Rajaraman","doi":"10.1016/j.jmir.2025.101933","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose/Aim</h3><div>Published literature suggests cannabis may be beneficial in the alleviation of symptoms related to cancer and radiation therapy treatment. There is limited research comparing use and attitudes regarding cannabis in this patient population prior to and after legalization of recreational cannabis. This study will assess cannabis use and attitudes towards cannabis in patients undergoing radiation therapy for cancer through a questionnaire similar to that used at the same cancer centre in early 2018.</div></div><div><h3>Methods/Process</h3><div>Patients were approached by their radiation therapists during their weekly review appointments at the cancer centre. Eligibility criteria included English-speaking patients over 18 years old undergoing radiation therapy for cancer. Participants received a study package containing the questionnaire in paper format, and a QR code for the online format. They were encouraged to anonymously complete the questionnaire using one of these methods during their appointment. A total of 202 questionnaires were completed, allowing comparability to a similar 2018 study which accrued 213. This methodology mirrored that of the previous study, enabling a direct comparison of results. All study procedures were approved by the Research Ethics Board of our institution.</div></div><div><h3>Results or Benefits/Challenges</h3><div>In this study, 210 study packages were accepted by patients, with a response rate of 96%, compared to the 2018 study which had a response rate of 88%. When assessing the current cannabis use of the population, 35/202 (17%) identified as active users in the 2024 study, similar to the 2018 study. When asked on a scale of 1 to 5, “Are you interested in learning more about medicinal marijuana?”, where 1 equated to “not interested”, 83/202 (42%) indicated they were not interested, compared to 45/241 (21%) in the 2018 study. When asked “Where are you most likely to go if you wanted to learn more about cannabis use and cancer?”, 150/202 (74%) selected “From a cancer doctor, nurse, or radiation therapist”, similar to the 2018 study. When current cannabis users were asked “Why are you currently using cannabis?”, a variety of answers were chosen, with the most popular being: “It helps me sleep better”, “Recreationally/for enjoyment”, and “Pain”.</div></div><div><h3>Conclusions/Impact</h3><div>Based on these findings, it is clear that patients are interested in learning more about the use of medicinal cannabis from health care professionals, despite the overall interest declining since the legalization of recreational cannabis. Cancer patients currently using medicinal cannabis are using it for a wide variety of symptom and side effect management, not limited to pain, nausea, and fatigue. Next steps include developing resources for both staff and patients on safe use of medicinal cannabis in cancer patients receiving radiation therapy, and conducting education sessions for the department on how to broach conversations and advise patients regarding its use.</div></div>","PeriodicalId":46420,"journal":{"name":"Journal of Medical Imaging and Radiation Sciences","volume":"56 1","pages":"Article 101933"},"PeriodicalIF":1.3000,"publicationDate":"2025-05-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of Medical Imaging and Radiation Sciences","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1939865425000839","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING","Score":null,"Total":0}
引用次数: 0

Abstract

Purpose/Aim

Published literature suggests cannabis may be beneficial in the alleviation of symptoms related to cancer and radiation therapy treatment. There is limited research comparing use and attitudes regarding cannabis in this patient population prior to and after legalization of recreational cannabis. This study will assess cannabis use and attitudes towards cannabis in patients undergoing radiation therapy for cancer through a questionnaire similar to that used at the same cancer centre in early 2018.

Methods/Process

Patients were approached by their radiation therapists during their weekly review appointments at the cancer centre. Eligibility criteria included English-speaking patients over 18 years old undergoing radiation therapy for cancer. Participants received a study package containing the questionnaire in paper format, and a QR code for the online format. They were encouraged to anonymously complete the questionnaire using one of these methods during their appointment. A total of 202 questionnaires were completed, allowing comparability to a similar 2018 study which accrued 213. This methodology mirrored that of the previous study, enabling a direct comparison of results. All study procedures were approved by the Research Ethics Board of our institution.

Results or Benefits/Challenges

In this study, 210 study packages were accepted by patients, with a response rate of 96%, compared to the 2018 study which had a response rate of 88%. When assessing the current cannabis use of the population, 35/202 (17%) identified as active users in the 2024 study, similar to the 2018 study. When asked on a scale of 1 to 5, “Are you interested in learning more about medicinal marijuana?”, where 1 equated to “not interested”, 83/202 (42%) indicated they were not interested, compared to 45/241 (21%) in the 2018 study. When asked “Where are you most likely to go if you wanted to learn more about cannabis use and cancer?”, 150/202 (74%) selected “From a cancer doctor, nurse, or radiation therapist”, similar to the 2018 study. When current cannabis users were asked “Why are you currently using cannabis?”, a variety of answers were chosen, with the most popular being: “It helps me sleep better”, “Recreationally/for enjoyment”, and “Pain”.

Conclusions/Impact

Based on these findings, it is clear that patients are interested in learning more about the use of medicinal cannabis from health care professionals, despite the overall interest declining since the legalization of recreational cannabis. Cancer patients currently using medicinal cannabis are using it for a wide variety of symptom and side effect management, not limited to pain, nausea, and fatigue. Next steps include developing resources for both staff and patients on safe use of medicinal cannabis in cancer patients receiving radiation therapy, and conducting education sessions for the department on how to broach conversations and advise patients regarding its use.
加拿大大麻合法化六年后癌症患者的大麻使用情况
目的已发表的文献表明,大麻可能有助于缓解与癌症和放射治疗有关的症状。在娱乐性大麻合法化之前和之后,比较这一患者群体对大麻的使用和态度的研究有限。这项研究将通过类似于2018年初在同一癌症中心使用的问卷调查,评估接受癌症放射治疗的患者对大麻的使用情况和态度。方法/过程患者在癌症中心接受每周一次的复查时,由放射治疗师接触患者。入选标准包括说英语的18岁以上接受癌症放射治疗的患者。参与者收到一份研究包,其中包含纸质形式的问卷,以及在线形式的QR码。他们被鼓励在预约期间使用其中一种方法匿名完成问卷。总共完成了202份问卷,与2018年的一项类似研究具有可比性,该研究共完成了213份问卷。这种方法反映了以前的研究,可以直接比较结果。所有的研究程序都得到了我们机构研究伦理委员会的批准。结果或益处/挑战在本研究中,患者接受了210个研究包,反应率为96%,而2018年的研究反应率为88%。在评估目前人口的大麻使用情况时,在2024年的研究中,35/202(17%)被确定为活跃用户,与2018年的研究相似。当被问及“你有兴趣了解更多关于药用大麻的知识吗?”,其中1代表“不感兴趣”,83/202(42%)表示不感兴趣,而2018年的研究中,这一比例为45/241(21%)。当被问及“如果你想了解更多关于大麻使用和癌症的信息,你最有可能去哪里?”, 150/202(74%)选择了“来自癌症医生、护士或放射治疗师”,与2018年的研究相似。当目前的大麻使用者被问及“你为什么目前在使用大麻?”的问题中,人们选择了各种各样的答案,其中最受欢迎的是:“它能帮助我睡得更好”、“娱乐/享受”和“疼痛”。结论/影响根据这些发现,患者显然有兴趣从卫生保健专业人员那里更多地了解医用大麻的使用情况,尽管自娱乐性大麻合法化以来,总体兴趣有所下降。目前使用药用大麻的癌症患者将其用于各种各样的症状和副作用管理,而不仅仅局限于疼痛,恶心和疲劳。接下来的步骤包括为接受放射治疗的癌症患者开发工作人员和患者安全使用药用大麻的资源,并为该部门举办关于如何就其使用展开对话和向患者提供建议的教育会议。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Journal of Medical Imaging and Radiation Sciences
Journal of Medical Imaging and Radiation Sciences RADIOLOGY, NUCLEAR MEDICINE & MEDICAL IMAGING-
CiteScore
2.30
自引率
11.10%
发文量
231
审稿时长
53 days
期刊介绍: Journal of Medical Imaging and Radiation Sciences is the official peer-reviewed journal of the Canadian Association of Medical Radiation Technologists. This journal is published four times a year and is circulated to approximately 11,000 medical radiation technologists, libraries and radiology departments throughout Canada, the United States and overseas. The Journal publishes articles on recent research, new technology and techniques, professional practices, technologists viewpoints as well as relevant book reviews.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信